Composition for treating metabolic syndrome
US8431552B2 · kind B2 · utility
11Cited by
7References
18Claims
0Family size
Inventor
Key dates
| Filing date | Jan 16, 2008 |
| Grant date | Apr 30, 2013 |
| Priority date | — |
| Expiry date | Nov 5, 2028 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P29/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to a composition that includes a first agent selected from the group consisting of an oxidative phosphorylation inhibitor, an ionophore, and an adenosine 5′-monophosphate-activated Protein kinase (AMPK) activator; a second agent that possesses anti-inflammatory activity; and a third agent that possesses serotonin activity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.